LON:FBT First Trust NYSE Arca Biotechnology UCITS ETF Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology UCITS ETF Please log in to your account or sign up in order to add this asset to your watchlist. GBX 1,375.11 +7.61 (+0.56%) (As of 07/1/2022 02:14 PM ET) Add Compare Share Today's Range 1,369.53▼ 1,375.3050-Day Range 1,220.30▼ 1,384.6052-Week Range 1,220.30▼ 1,560.40Volume71 shsAverage Volume1,602 shsMarket Capitalization£4.06 billionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsInsider TradesHeadlinesOptions Chain View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive FBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology UCITS ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address FBT Stock Forecast (MarketRank)Overall MarketRank™0.88 out of 5 starsAnalyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for First Trust NYSE Arca Biotechnology UCITS ETF. Previous Next 4.4 Community Rank Outperform VotesFirst Trust NYSE Arca Biotechnology UCITS ETF has received 72 “outperform” votes. (Add your “outperform” vote.)Underperform VotesFirst Trust NYSE Arca Biotechnology UCITS ETF has received 36 “underperform” votes. (Add your “underperform” vote.)Community SentimentFirst Trust NYSE Arca Biotechnology UCITS ETF has received 66.67% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about First Trust NYSE Arca Biotechnology UCITS ETF and other stocks. Vote “Outperform” if you believe FBT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe FBT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldFirst Trust NYSE Arca Biotechnology UCITS ETF does not currently pay a dividend.Dividend GrowthFirst Trust NYSE Arca Biotechnology UCITS ETF does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, First Trust NYSE Arca Biotechnology UCITS ETF insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of First Trust NYSE Arca Biotechnology UCITS ETF is -1,250.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of First Trust NYSE Arca Biotechnology UCITS ETF is -1,250.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioFirst Trust NYSE Arca Biotechnology UCITS ETF has a P/B Ratio of 723.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About First Trust NYSE Arca Biotechnology UCITS ETF (LON:FBT)Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content. The company operates under the brand name of Blackbird. The company was founded in 1998 and is based in London, the United Kingdom.Read More FBT Stock News HeadlinesFebruary 24, 2022 | apnews.comCORRECTING and REPLACING First Trust Advisors L.P. Announces Distribution for First Trust Enhanced Short Maturity ETFJuly 6, 2020 | www.lse.co.ukTrading/Spreadbetting boardMay 1, 2019 | finance.yahoo.comForbidden Technologies plc: Deltatre Extends Blackbird Partnership for Production of Sports Clips and HighlightsApril 23, 2019 | finance.yahoo.comDoes Forbidden Technologies plc's (LON:FBT) Past Performance Indicate A Weaker Future?April 4, 2019 | finance.yahoo.comGfinity Extends Blackbird Partnership for the Delivery of esports Clips and HighlightsApril 3, 2019 | finance.yahoo.comNAB 2019: Xytech Systems and Blackbird Partner to Streamline Asset Management Process for MediaPulse UsersMarch 13, 2019 | www.bloomberg.comForbidden Technologies PLCMarch 5, 2019 | finance.yahoo.comIMG Grows and Extends Blackbird Partnership for Another Three YearsDecember 19, 2018 | finance.yahoo.comTownNews Extends Blackbird Adoption with Block Communications DeploymentSee More Headlines Industry, Sector and Symbol Stock ExchangeLON Industry Software - Application Sub-IndustryN/A SectorComputer and Technology Current SymbolLON:FBT CUSIPN/A CIKN/A Webwww.forbidden.co.uk Phone+44-20-88797245FaxN/AEmployees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.04 Current Ratio9.42 Quick Ratio9.27 Sales & Book Value Annual Sales£870.31 thousand Price / Sales4,668.75 Cash FlowGBX 388 per share Price / Cash Flow3.54 Book ValueGBX 1.90 per share Price / Book723.74Miscellaneous Outstanding Shares295,486,016Free FloatN/AMarket Cap£4.06 billion OptionableOptionable BetaN/A First Trust NYSE Arca Biotechnology UCITS ETF Frequently Asked Questions How has First Trust NYSE Arca Biotechnology UCITS ETF's stock price performed in 2022? First Trust NYSE Arca Biotechnology UCITS ETF's stock was trading at GBX 1,468.98 at the beginning of the year. Since then, FBT stock has decreased by 6.4% and is now trading at GBX 1,375.11. View the best growth stocks for 2022 here. Who are First Trust NYSE Arca Biotechnology UCITS ETF's key executives? First Trust NYSE Arca Biotechnology UCITS ETF's management team includes the following people: Mr. Ian McDonough, CEO & Director (Age 47)Mr. Stephen B. Streater, Founder, Director of R&D and Exec. DirectorMr. Stephen James White, Chief Operating & Financial Officer and Director (Age 48)Adrian Lambert, Marketing DirectorRachel Darcy, Sales Director Who are some of First Trust NYSE Arca Biotechnology UCITS ETF's key competitors? Some companies that are related to First Trust NYSE Arca Biotechnology UCITS ETF include Open Text (OTEX), AVEVA Group (AVV), The Descartes Systems Group (DSG), Nemetschek (NEM), The Sage Group (SGE), Avast (AVST), Lightspeed Commerce (LSPD), Kinaxis (KXS), Rocket Internet (RKET), Sophos Group plc (SOPH.L) (SOPH), Enghouse Systems (ENGH), RIB Software (RIB), Kainos Group (KNOS), Blue Prism Group (PRSM) and Kape Technologies (KAPE). View all of FBT's competitors. What other stocks do shareholders of First Trust NYSE Arca Biotechnology UCITS ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust NYSE Arca Biotechnology UCITS ETF investors own include Taylor Wimpey (TW), ARK Genomic Revolution Multi-Sector ETF (ARKG), Johnson & Johnson (JNJ), Weyerhaeuser (WY), AbbVie (ABBV), ARK Innovation ETF (ARKK), Alibaba Group (BABA), Bristol-Myers Squibb (BMY), Global X Robotics & Artificial Intelligence ETF (BOTZ) and Caterpillar (CAT). What is First Trust NYSE Arca Biotechnology UCITS ETF's stock symbol? First Trust NYSE Arca Biotechnology UCITS ETF trades on the London Stock Exchange (LON) under the ticker symbol "FBT." How do I buy shares of First Trust NYSE Arca Biotechnology UCITS ETF? Shares of FBT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is First Trust NYSE Arca Biotechnology UCITS ETF's stock price today? One share of FBT stock can currently be purchased for approximately GBX 1,375.11. How much money does First Trust NYSE Arca Biotechnology UCITS ETF make? First Trust NYSE Arca Biotechnology UCITS ETF (LON:FBT) has a market capitalization of £4.06 billion and generates £870.31 thousand in revenue each year. How many employees does First Trust NYSE Arca Biotechnology UCITS ETF have? First Trust NYSE Arca Biotechnology UCITS ETF employs 20 workers across the globe. How can I contact First Trust NYSE Arca Biotechnology UCITS ETF? First Trust NYSE Arca Biotechnology UCITS ETF's mailing address is Tuition House, 27-37 St. Georges Road, LONDON, SW19 4EU, United Kingdom. The official website for First Trust NYSE Arca Biotechnology UCITS ETF is www.forbidden.co.uk. The company can be reached via phone at +44-20-88797245. This page (LON:FBT) was last updated on 7/1/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here